| CARYX | ECRAX | CARYX / ECRAX | |
| Total Expense Ratio | 0.77 | 1.87 | 41% |
| Annual Report Gross Expense Ratio | 0.77 | 1.98 | 39% |
| Fund Existence | 12 years | 15 years | - |
| Gain YTD | 8.177 | 5.833 | 140% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.57B | 215M | 1,197% |
| Annual Yield % from dividends | 2.68 | 1.52 | 177% |
| Returns for 1 year | 15.69 | 12.94 | 121% |
| Returns for 3 years | 38.87 | 27.85 | 140% |
| Returns for 5 years | 8.63 | 9.00 | 96% |
| Returns for 10 years | 42.43 | 35.16 | 121% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SYZ | 30.12 | -0.03 | -0.11% |
| Lazard US Systematic Small Cap Eq ETF | |||
| DEUS | 66.69 | -0.14 | -0.21% |
| Xtrackers Russell US Multifactor ETF | |||
| XUDV | 32.37 | -0.13 | -0.41% |
| Franklin U.S. Dividend Mltplr Idx ETF | |||
| PPLT | 14.96 | -0.07 | -0.47% |
| abrdn Physical Platinum Shares ETF | |||
| FMED | 28.00 | -0.73 | -2.53% |
| Fidelity Disruptive Medicine ETF | |||